Startup entity
Of the tracked stories, 2 of 2 also mention Colossal Biosciences, the most common co-covered peer. The 140-day window averages about 0.1 stories each week. They are better corroborated than the beat average, carrying 3 original sources each against 2.9 for the same window.
Last mentioned: Jul 21, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 2 of 2 also mention Colossal Biosciences, the most common co-covered peer. The 140-day window averages about 0.1 stories each week. They are better corroborated than the beat average, carrying 3 original sources each against 2.9 for the same window. The clearest coverage concentration is funding: 1 of 2 stories, with the rest divided among 1 other category. Their average consequence score of 7.5 runs above the beat's 6.7 for that window. We currently track 2 Startup stories that mention Ben Lamm, published between March 4, 2026 and July 21, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 1162 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Ben Lamm. Shared-story counts are live from our verified record — not editorial picks.
Venture capital’s most audacious bet, Colossal Biosciences, is seeking a valuation of $20–$30 billion — a nearly 3x jump — as it generates revenue, spins out high-value startups, and turns its de-extinction mission into a startup factory with government clients and AI-driven assets.
Colossal Biosciences is advancing its mission to revive the woolly mammoth by 2028, sparking intense debate over the ethics of de-extinction. While the startup has secured over $225 million in venture capital, critics argue the project is a costly distraction from urgent conservation efforts for living species.
Ben Lamm is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
